Lead sponsor
Yale University
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
195
Total enrollment
23
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
1
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's DiseaseAlzheimer's diseasePh 2Completed159
Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923Study partner/caregiver requiredPh 1Completed36